Fingerprint
Dive into the research topics of 'Randomized Phase II study of gemcitabine plus cisplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically